XBRU
FLOB
Market cap662mUSD
Jun 18, Last price
59.00EUR
1D
-1.67%
1Q
-4.84%
Jan 2017
-52.98%
Name
Floridienne SA
Chart & Performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Floridienne S.A., established in Waterloo, Belgium in 1898, is an international company that operates through its various subsidiaries across three core sectors: chemicals, gourmet food, and life sciences. Its Chemicals division specializes in the production of plastic additives, including stabilizers for PVC and fire-retardant agents for plastics. This division also handles the recycling of nickel/cadmium, nickel-metal hybrid, and lithium-ion rechargeable batteries, and supplies zinc salts for galvanization. Furthermore, it is responsible for developing and manufacturing calcium/zinc-based and organic stabilizers. The Gourmet Food division is dedicated to creating and distributing a diverse range of premium and celebratory food items. These offerings span from appetizers and prepared dishes like snails, scallops, stuffed shellfish, and smoked salmon, to seafood salads, flaky pastry bites, and various ethnic meals. The product line also includes an assortment of cold and warm sauces, vinegars, condiments, jams, and spreads. A unique focus of this division is the provision of specialized food products designed for individuals experiencing swallowing difficulties. Finally, the Life Sciences division develops and commercializes natural technologies and products tailored for the agricultural, agri-foodstuff, healthcare, parapharmaceutical, and cosmetics industries. It offers services such as plant proteases and integrated pest management solutions. Additionally, this division allocates resources to researching and implementing solutions, particularly in the realm of chemical communication involving taste and olfactory receptors in mammals.
Valuation
Title EUR in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||